Healthcare

No link between Ozempic, Wegovy and suicide, EU drug regulators say
In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’
Three moves the OCP is making around preferred provider networks
The Ontario College of Pharmacists has announced it will take steps to address preferred provider networks—including exploring stronger regulatory responses.

Certain gut bacteria lowers cholesterol levels: study

Could boosting beneficial gut bacteria help fight heart disease?
Diltiazem increases bleeding risk in older adults receiving apixaban or rivaroxaban

Diltiazem used for ventricular rate control in patients with atrial fibrillation inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation.
Proposed class-action suit against Shoppers and Loblaw claims terminated owners were berated and ‘perp walked’ out of their stores

Filed by pharmacist Sivajanan Sivapalan, the lawsuit alleges Shoppers made ‘frivolous and vexatious’ complaints to the Ontario College of Pharmacists about associate-owners after ending their franchise agreements.
Workers warn of dangers if six Public Health Ontario labs close

Public Health Ontario first proposed the consolidation of its 11 laboratories in 2017, but the government has not acted.
Alberta closing in on new deal to pay family doctors

The details of the framework announced Wednesday have yet to be hammered out, including specific rates.
How to become a pharmacy leader

In the first part of a new series on Leadership, Kristen Watt describes the indirect path she took to become a well-known face and voice in pharmacy.
‘Expensive, ineffective, and possibly harmful’: CBD is no panacea for pain according to new review

A new article in the Journal of Pain looked at the results of 16 randomized, double-blind trials published on CBD and pain since 2019.
Editorial: The Emergency Care Issue

The squeeze is on for Canada’s emergency departments.

No link between Ozempic, Wegovy and suicide, EU drug regulators say

Three moves the OCP is making around preferred provider networks

Certain gut bacteria lowers cholesterol levels: study

Diltiazem increases bleeding risk in older adults receiving apixaban or rivaroxaban

Proposed class-action suit against Shoppers and Loblaw claims terminated owners were berated and ‘perp walked’ out of their stores

Workers warn of dangers if six Public Health Ontario labs close

Alberta closing in on new deal to pay family doctors

How to become a pharmacy leader

‘Expensive, ineffective, and possibly harmful’: CBD is no panacea for pain according to new review

Editorial: The Emergency Care Issue